Skip to main content

Advertisement

Table 1 Baseline characteristics for all hemato-oncology patients undergoing line insertion

From: Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients

Patient characteristics PICC (n = 346) LTSTC (n = 237)
Median age (range) 49.7 (15-77) 50.8 (17-72)
Gender:   
Females (%) 49 49
Males (%) 51 51
Hematological malignancy:   
AML (%) 36 25
ALL (%) 14 10
HL (%) 5 7
NHL (%) 24 15
MM (%) 15 27
Chronic leukemia (%) 4 9
Misc (%) 2 7
Disease stage:   
Newly diagnosed (%) 27 10
Relapsed/Refractory (%) 52 53
Remission (%) 21 37
Median duration of dwell time of line in days (range) 64.9 (1-519) 109.4 (1-783)
  1. NB: AML = Acute Myeloid Leukemia; ALL = Acute Lymphoblastic Leukemia; HL = Hodgkin Lymphoma; NHL = Non-Hodgkin Lymphoma; MM = Multiple Myeloma; Misc. = Miscellaneous consisting of Myelofibrosis, Myelodysplastic Syndrome and Aplastic Anemia; Chronic Leukemia consisting of Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia and T-Prolymphocytic Leukemia; PICC = Peripherally-Inserted Central Venous Catheter; LTSTC = Long-term skin-tunneled venous catheter.